Skip to main content

Current status of COVID-19 vaccine development

December 30, 2020
Presented by Larry Corey, MD Past President and Director, Professor of Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Professor, Medicine and Laboratory Medicine, University of Washington Corey is an internationally renowned expert in virology, immunology and vaccine development. His research focuses on herpes viruses, HIV, the novel...

NIH awards seven-year funding to Cohen and El-Sadr for leadership of HIV Prevention Trials Network

November 30, 2020
AIDS Clinical Trials Group, co-led by UNC’s Joseph Eron, MD, also re-funded for seven years Myron S. Cohen, MD, director of UNC’s Institute for Global Health and Infectious Diseases, and Wafaa El-Sadr, MD, MPH, MPA, director of ICAP at Columbia University, have received a seven-year award from the National Institutes...

NIH awards $25 million to UNC’s Global HIV Clinical Trials Unit

November 30, 2020
  The National Institutes of Health has awarded University of North Carolina’s Institute for Global Health & Infectious Diseases nearly $25 million over seven years to continue operating its Global HIV Clinical Trials Unit, or CTU. The new funding will support HIV treatment and prevention in adults, children and pregnant...

‘Major advance’: Long-acting injectable more effective than daily pill in preventing HIV

November 10, 2020
Study led by female investigators enrolled women living with HIV in sub-Saharan Africa A long-acting injectable drug, cabotegravir, is safe and more effective than a daily pill in preventing HIV acquisition, according to results from a study of 3,127 cisgender women in sub-Saharan Africa. Led by UNC researchers beginning in...

NIH awards Cohen, FHI $9.2 million for development of COVID prevention studies

July 21, 2020
The National Institutes of Health has awarded Myron Cohen, MD, director of UNC’s Institute for Global Health and Infectious Diseases, and FHI 360 $9.2 million to support research through the new COVID Prevention Network (CoVPN). The National Institute of Allergy and Infectious Diseases at the National Institutes of Health has...

‘Landmark’ study finds long-acting injectable drug highly effective in preventing HIV

May 18, 2020
  Large-scale study funded by NIAID and ViiV Healthcare halted early after cabotegravir, dosed every two months, shows higher efficacy than daily oral pill.   The decades-long search for a vaccine to prevent HIV reached a new milestone as results from HPTN 083, a global large-scale study, show that the...

Cohen, Fowler inducted into UNC’s Order of the Golden Fleece

May 6, 2020
Myron Cohen, MD, Yeargan-Bate Distinguished Professor of medicine, microbiology, and immunology and epidemiology and director of the Institute for Global Health and Infectious Diseases, and Wesley Fowler, MD, associate dean for medical alumni affairs and professor of obstetrics and gynecology,and have been inducted into the Order of the Golden Fleece,...

Learning the rules of emerging infections

November 9, 2016
Dr. Cohen talks about the rules to fighting infections during the Lancet-CAMS health summit.   Myron Cohen, chief of UNC’s Division of Infectious Diseases and director of the Institute for Global Health and Infectious Diseases, visited with UNC Project-China staff and partners in October 2016, making presentations in three cities...